CytoDyn
Biotechnology Research • 
VANCOUVER, Washington 98660, United States • 21-50 Employees
Company overview
| Headquarters | VANCOUVER, Washington 98660, United States |
| Phone number | +13609808524 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Biotechnology, Cancer, Pharmaceuticals, Hiv/Aids, Nash |
| Employees | 21-50 |
| Socials |
Key Contacts at CytoDyn
Jay Lalezari
Chief Executive Officer At Cytodyn Inc.
Minxiu Chen
Director
Alok Krishen
Senior Director, Head Of Biostatistics
CytoDyn Email Formats
CytoDyn uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@cytodyn.com), used 75% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@cytodyn.com | 75% |
{first initial}{last name} | jdoe@cytodyn.com | 25% |
About CytoDyn
CytoDyn is in late-stage clinical development of leronlimab, a CCR5 receptor antagonist, to be used as a platform drug for various therapeutic indications, including NASH, NASH/HIV, oncology, and HIV. The CCR5 receptor is a protein located on the surface of various cells including white blood cells, stellate cells which produce scar tissue in the liver, cells that undergo malignant transformation, and is the predominant co-receptor needed for certain strains of HIV to infect healthy T-cells. The CCR5 receptor serves as a receptor for chemical attractants called chemokines. Chemokines are the key orchestrators of leukocyte trafficking by attracting immune cells to the sites of inflammation. Leronlimab is a humanized monoclonal antibody that is a once-a-week subcutaneous injection that can also be administered intravenously. Leronlimab is a competitive rather than allosteric inhibitor of the CCR5 receptor. This mechanism of action of binding competitively to the CCR5 receptor differentiates leronlimab from all other CCR5 antagonists.
CytoDyn revenue & valuation
| Annual revenue | $266,000 |
| Revenue per employee | $12,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $851,200 |
| Total funding | $2,900,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
CytoDyn has 6 employees across 5 departments.
Departments
Number of employees
CytoDyn Tech Stack
Discover the technologies and tools that power CytoDyn's digital infrastructure, from frameworks to analytics platforms.
Web servers
PaaS
JavaScript libraries
Tag managers
Webmail
JavaScript libraries
Security
JavaScript libraries
Miscellaneous
UI frameworks
Analytics
Miscellaneous
France
United Kingdom
Frequently asked questions
4.8
40,000 users
